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In vitro and in vivo effects of insulin-
producing cells generated by xeno-
antigen free 3D culture with RCP 
piece
Tetsuya Ikemoto1, Rui Feng1, Shu-ichi Iwahashi1, Shinichiro Yamada1, Yu Saito1, Yuji Morine1, 
Satoru Imura1, Munehide Matsuhisa  2 & Mitsuo Shimada1
To establish widespread cell therapy for type 1 diabetes mellitus, we aimed to develop an effective 
protocol for generating insulin-producing cells (IPCs) from adipose-derived stem cells (ADSCs). We 
established a 3D culture using a human recombinant peptide (RCP) petaloid μ-piece with xeno-antigen 
free reagents. Briefly, we employed our two-step protocol to differentiate ADSCs in 96-well dishes and 
cultured cells in xeno-antigen free reagents with 0.1 mg/mL RCP μ-piece for 7 days (step 1), followed by 
addition of histone deacetylase inhibitor for 14 days (step 2). Generated IPCs were strongly stained with 
dithizone, anti-insulin antibody at day 21, and microstructures resembling insulin secretory granules 
were detected by electron microscopy. Glucose stimulation index (maximum value, 4.9) and MAFA 
mRNA expression were significantly higher in 3D cultured cells compared with conventionally cultured 
cells (P < 0.01 and P < 0.05, respectively). The hyperglycaemic state of streptozotocin-induced diabetic 
nude mice converted to normoglycaemic state around 14 days after transplantation of 96 IPCs under 
kidney capsule or intra-mesentery. Histological evaluation revealed that insulin and C-peptide positive 
structures existed at day 120. Our established xeno-antigen free and RCP petaloid μ-piece 3D culture 
method for generating IPCs may be suitable for clinical application, due to the proven effectiveness in 
vitro and in vivo.
Islet transplantation (ICTx) is one of the therapeutic options for patients with type 1 diabetes mellitus and can 
remove the need for insulin injections and associated complications1,2. However, ICTx still faces several obstacles, 
such as the requirement of a large islet yield2, the fragility of the isolated islets3 and severe donor shortages in 
some counties, such as Japan4, which need to be addressed before widespread clinical use.
To solve these issues, we have focused on stem cells for generating insulin-producing cells (IPCs). We inves-
tigated adipose-derived stem cells (ADSCs) as a new cell source5,6, not only for their trophic effects but also for 
their multi-potency. We focused on these cells because ADSCs can be obtained from the patient’s own fat tissue 
under local anaesthesia, and auto-ADSC transplantation has fewer ethical problems compared with the use of 
induced pluripotent stem or embryonic stem cells. Furthermore, transplanted induced pluripotent stem cells or 
transfected embryonic stem cells can harbour DNA damage, and thus carry a high risk of cell transformation and 
carcinogenesis7. ADSCs do not show these limitations and can be readily applied in clinical trials8,9. Moreover, 
some reports indicate that ADSCs show superior potential for differentiation into various cell types10, that suf-
ficient cell numbers can be easily obtain with ADSC compared with other types of stem cells, for example, bone 
marrow derived stem cells11.
We previously established an accelerated IPC generation protocol from ADSCs using histone deacetylase 
inhibitor (HDACi), using modified protocols from previous studies12–15. HDAC inhibition is reported to be 
a strong driver of pancreatic cell lineage progenitors16. Therefore, we investigated the use of an HDACi (val-
proic acid) for acceleration of IPC formation and established a rapid and easy two-step protocol17. Although we 
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achieved simplification and shorten culture duration, some hurdles still remained for clinical application, such as 
the presence of xeno-antigens, poor cell expansion rate and unexamined in vivo effectiveness.
The three-dimensional (3D) culture system has demonstrated many advantages for cell expansion and cell 
transplantation. Various 3D culture systems have been established, such as those that use matrigel, scaffolds, 
special dishes and floating culture systems18–21. To improve our IPC generation protocol, we used the human 
recombinant peptide (RCP) petaloid μ-piece obtained from FUJI FILM Co. Ltd. This material showed advantages 
for islet cell culture and cell transplantation22 in a murine experimental model. Briefly, this RCP μ-piece supports 
the formation of a large cell cluster, named as a ‘CellSaic’ because cells and the RCP μ-piece are merged like a 
mosaic, without central necrosis. The CellSaic maintains cell viability in vivo when transplanted with target cells. 
Additionally, CellSaic is xeno-antigen free and clinical grade has been achieved23.
Here we report our established 3D culture system that is based on our easy and rapid two-step IPC generation 
protocol and free of xeno-antigen. We also demonstrate in vitro and in vivo results that support the potential 
clinical application of the generated IPCs.
Results
The RCP piece 3D culture system generates cells with IPC morphology. We generated IPCs 
from ADSCs under 3D (with μ-RCP piece) or conventional conditions using our two-step protocol (Fig. 1A). 
Morphological changes were examined every two days during the culture, and representative images at day 1, day 
7, and day 21 are shown in Fig. 1B. A sphere-like cell cluster formed within 24 h after initiation of the 3D culture 
and maintained formation until day 21. These cells were strongly stained with dithizone at day 21 (Fig. 1C, upper 
right), but not well stained at day 9 (Fig. 1C, upper left) or in 2D culture (as control) at day 21 (Fig. 1C, lower), 
and cell formation and nuclei were maintained and showed good cell condition without necrosis under a light 
microscope (Fig. 1D).
Immunohistochemical staining showed that viable IPCs secreted insulin. As determined by flu-
orescein diacetate/propidium iodide (FDP/PI) staining (Fig. 2A), the 3D cultured IPCs on day 21 showed sig-
nificantly better cell viability compared with the 2D culture cells (P < 0.01, unpaired t-test, Fig. 2B). Moreover, 
Figure 1. Our established protocol for generating insulin-producing cells in 3D culture using our two-step 
protocol. (A) Schematic showing the two-step protocol for generating IPCs from ADSCs. §: in the case of 
ordinary plate culture (conventional 2D monolayer culture). PE: pancreatic endoderm, IPC: insulin-producing 
cell. (B) Images of cell formation at each step are shown. ADSCs rapidly formed a cluster in 24 h and the cluster 
was maintained until day 21 (step 2). (C) The generated cell cluster was strongly stained with dithizone dye at 
day 21 after the start of step 1 (upper left), but was not well stained at day 9 (upper left) and 2D cultured control 
at day 21 (bottom). Scale bar, 100 μm. (D) Formation of a ‘CellSaic’ with viable cells and RCP petaloid μ-piece. 
Scale bar, 100 μm.
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the cytoplasm of 3D cultured IPCs showed positive staining for insulin in immunological fluorescence images 
(Fig. 2C,D). Light microscopy imaging also showed positive staining for insulin of the cytoplasm (Fig. 2E).
We next investigated mRNA expression of MAFA, a maturation marker of islet β-cells. The expression of 
MAFA mRNA in 3D cultured IPCs at day 21 was significantly higher than that of conventional 2D cultured IPCs 
at day 21 (P = 0.00449, unpaired t-test; Fig. 2F).
Generated IPCs did not show significant toxicity. We also investigated the cell toxicity of generated 
IPCs by evaluating the effects on the proliferation rate of human fibroblasts. The co-culture of IPCs at day 21 did 
not show significant adverse effects on the proliferation rate of human fibroblasts compared with the control 
group, although 5-FU addition showed significantly reduced viability (P < 0.05, one-way ANOVA, Fig. 2G).
Electron microscopy shows insulin secretion granule-like structures in 3D cultured 
IPCs. Electron microscopic analysis revealed that the nuclei of 3D cultured IPCs contained dense cystic micro-
structures (Fig. 3A) and organelles, such as rough endoplasmic reticulum and mitochondria (Fig. 3B). Moreover, 
these dense cystic microstructures in the generated IPCs morphologically resembled insulin secretion granules 
observed in normal islets from naïve rat pancreas (Fig. 3C,D).
Generated IPCs show a good glucose stimulation index (SI). The insulin concentration in the super-
natant of IPCs at day 21 was increased when these cells were incubated in ‘low glucose’ medium (5 mM) for 1 h 
and then moved to ‘high glucose’ medium (45 mM) for 1 h. The average glucose SI of 3D cultured IPCs was sig-
nificantly higher compared with conventional 2D cultured IPCs (P < 0.05, Welch’s test, Fig. 4). The maximum SI 
value in 3D cultured IPCs at day 21 was 4.9.
Generated IPCs converted from a hyperglycaemic to a normoglycaemic state after transplan-
tation. Non-fasting blood glucose levels of streptozotocin-induced diabetic nude mice decreased gradually in 
IPC transplantation groups, but not in the sham group. Levels were below 200 mg/dl around 14 post-transplant 
days and were maintained up to 120 post-transplant days (17 weeks) in the sub-renal capsule transplantation 
group (n = 5) and intra-mesentery transplantation group (n = 5). Hyperglycaemic state was not converted in the 
sham group (n = 4). The average non-fasting blood glucose levels of each group up to 60 post-transplant days are 
shown in Fig. 5A.
Figure 2. Cell quality of IPCs generated by the 3D cultured protocol was better than IPCs from conventional 
monolayer culture. (A) The cell viability of 3D cultured IPCs at day 21 was determined by FDP/PI staining. 
Green: FDP staining, red: PI staining, orange: merged image. Scale bar, 100 μm. (B) Absorbance at 450 nm 
showed significantly better cell viability of 3D cultured IPCs compared with IPCs from conventional 2D culture 
method. **P < 0.01, un-paired t-test. (C) Immunofluorescence of generated IPCs at day 21. Red: insulin, blue: 
DAPI. Scale bar, 100 μm. (D) The larger image shows the insulin-positive area was the cytoplasm. Red: insulin, 
blue: DAPI. (E) Light microscopy analysis also showed the cytoplasm of generated IPCs was positive for insulin 
staining. Scale bar, 10 μm. R: RCP petaloid μ-piece, stained blue. (F) MAFA mRNA expression was significantly 
higher in 3D cultured IPCs compared with IPCs from conventional 2D culture method by unpaired t-test. 
**P < 0.01. Error bar indicates standard deviation. (G) Generated IPCs did not show significant adverse effects 
on human dermal fibroblasts in cell toxicity, although 100 μM 5-FU addition showed significantly reduced 
viability. *P < 0.05, one-way ANOVA.
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Figure 3. Electron microscopic images of microstructures in IPCs. (A) Generated 3D cultured IPCs at day 21 
showed clear nuclei. Nc: nucleus, R: RCP petaloid μ-piece. Scale bar, 5 μm. (B) Generated 3D cultured IPCs 
at day 21 also showed organelles. M: mitochondria, ER: endoplasmic reticulum. Scale bar, 1 μm. (C) Control: 
section from naïve rat pancreas. Naïve rat islets show dense cystic microstructures. ER: endoplasmic reticulum, 
G: secretory granule. Scale bar, 1 μm. (D) The same microstructures morphologically resembling secretory 
granules existed in generated IPCs at day 21. G: secretory granule. Scale bar, 1 μm.
Figure 4. Glucose stimulation index of IPCs generated by the 3D cultured protocol was significantly higher 
than IPCs generated by conventional 2D culture. The lines in the boxes show the median values, and the error 
bar shows the standard deviation. Unpaired t-test, **P < 0.01.
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Transplanted IPCs showed strong insulin and VEGF immunostaining. Macroscopic investigations 
for IPC-transplanted mice at day 120 post-transplantation revealed no macroscopic teratomas and carcinomas 
around transplanted sites (Fig. 5B). The kidney at day 7 and at day 120 were extirpated and investigated micro-
scopically. Light microscopy imaging revealed that transplanted IPCs under renal capsule at day 7 (Fig. 5C, 
upper) and at day 120 show few central necrosis, and showed insulin staining by immunofluorescence (Fig. 5C, 
middle right). Some parts of this structure were strongly stained by C-peptide (Fig. 5C, lower left). Transplanted 
IPCs at day 7 also showed strong expression of VEGF (Fig. 5C, middle left).
Figure 5. In vivo study. (A) Non-fasting blood glucose levels were decreased gradually after transplantation 
and measured below 200 mg/dl around 14 post-transplant days and maintained up to 60 post-transplant days in 
sub-renal capsule group (n = 5) and intra-mesentery group (n = 5). †: death. (B) No abnormal tumor formation 
was observed in each transplanted site at 120 post-transplant days. Left: around IPC transplanted right kidney, 
Right: mesentery. (C) Upper left. Transplanted CellSaic under kidney capsule at day 7. Central necrosis was 
not observed. Haematoxylin-eosin staining. Original magnification, ×400. Upper right. Continuous section of 
upper left was stained by anti-insulin antibody. Cytoplasm of IPC in CellSaic was strongly stained for insulin. 
Original magnification, ×400. Middle left. Transplanted IPCs at day 7 also showed strong expression of VEGF. 
Original magnification, ×400. Middle right. Transplanted CellSaic under kidney capsule at day 120. Central 
necrosis was hardly observed. Cytoplasm of IPC in CellSaic was strongly stained for insulin. RCP pieces were 
vanished, considered to have been absorbed. Original magnification, ×400. Lower. Some parts of this structure 
were strongly stained by C-peptide. Original magnification, ×800.
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Discussion
Repeated ICTx is recommended to increase the possibility of achieving insulin-free status, and more effective 
immunosuppression for long-lasting effects of ICTx is expected even though ICTx has been undergone clinically 
in Europe and North America. However, transplant surgeons in severe donor-shortage counties such as Japan 
have struggled to find a new cell source for ICTx. To solve these and other urgent issues for ICTx2,24,25, regenera-
tive medicine has been a subject of focus and thus the multipotency abilities of stem cells have been investigated. 
We focused on ADSCs among mesenchymal stem cells, as these cells can be used for procurement with less 
invasiveness methods and ADSCs were reported to have more multipotency compared with other cell sources26,27.
We previously established an easy and rapid differentiation protocol of IPCs from ADSCs. Despite the promis-
ing preliminary results, the method showed some issues to be addressed before clinical application. These hurdles 
included a relatively poor cell expansion rate12,28, the requirement for elimination of xeno-antigen29, and evalua-
tion of whether beneficial effects are realized in recipients30. Here we developed a 3D culture system with a RCP 
petaloid μ-piece to successfully generate effective IPCs that marked 65.6% of cell expansion rate (according to 
DNA quantity, data not shown) and reasonable SI value. Moreover, this RCP petaloid μ-piece is xeno-antigen free 
and is provided as clinical grade22,23. Our established two-step generation protocol is thus a xeno-antigen-free 
protocol. We also demonstrated the generation of effective IPCs in vitro with microstructures and showed they 
are viable insulin releasing cells by electron microscopy. Notably, the average diameter of these generated IPCs is 
relatively large, and thus further investigations are required to examine why central necrosis rarely occur, as well 
as the underlying mechanisms and in vivo pathological effects. Previous studies have shown that in vitro gener-
ated cells may not show ideal effects in vivo30,31. Indeed, the effectiveness of generated IPCs differentiated from 
same cell number with conventional culture (2D) was limited and unstable (data not shown). Pathological analy-
sis suggests this might be due to poor angiogenesis compared with 3D cultured transplantation results. Therefore, 
we performed in vivo transplantation experiments with the IPCs generated by our 3D and xeno-antigen free 
protocol. The non-fasting blood glucose level of STZ-induced diabetic immunodeficient nude mice showed the 
conversion from hyperglycaemia to normoglycaemia in mice with IPCs transplanted in sites such as under kidney 
capsule or intra-mesentery, and not in mice with injection in intra-femoral muscle. We are currently performing 
experiments with more mice in each group. We speculate that the poor angiogenesis or destruction of trans-
planted IPCs might occur from mechanical compression (data not shown). The normalization speed and blood 
glucose level were superior in intra-mesentery IPC transplantation than those with the renal capsule approach, 
which may be due to the difference in angiogenesis as described above. This glycaemic state was maintained 
at least until 120 post-transplant days. According to our previous experiments3,4,32,33 and reported studies34,35, 
one human IPC has the same insulin release activity in vivo of three international equivalent freshly isolated 
human islets, and graft survivals and endocrine activity were equal to superior than that of islet transplanta-
tion. Moreover, ICTx requires allogenic multi-donors-one-recipient transplantation36, and generation from the 
patient’s own small subcutaneous fat tissue under local anaesthesia can undergo repeated auto-transplantation 
with few ethical problems11. Although we showed preliminary data for the risk of carcinogenesis and cell toxicity 
of generated IPCs, a preclinical trial will be required to compare the 3D generated IPCs with islet transplantation 
once several questions are addressed regarding the generated IPCs, such as toxicity tests, elimination methods 
for undifferentiated cells, the decision of prompt transplantation site and dividing cell batches11,37,38. To address 
requirements of governmental regulations, we are now planning higher accuracy cytotoxicity LDH assay, soft 
agar colony forming test as cell transformation assay in vitro, and in vivo assay using NOD/Shi-scid, IL-2Rγnull 
or NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ mice for proof of concept acquisition. However, the elimination of immature 
cells is very important. Dithizone staining is used for the evaluation of cell maturation; however, this method is a 
relative and destructive4,39 evaluation method. Thus, we have investigated a non-destructive evaluation approach 
to distinguish immature IPCs using zinc ion concentration in the supernatant of cultured IPCs (manuscript sub-
mitted). Moreover, whether generated IPCs from the fat tissue of a type 1 diabetic patient undergo destructions 
when these IPCs are transplanted in autoimmune disease patients will require investigation40. Notably, our newly 
developed protocol to generate IPCs from ADSCs shows several advantages, such as xeno-antigen free, no genetic 
manipulation, effective culture system, low ethical problem from small fat tissue procurement under local anaes-
thesia to auto-transplantation, no immunosuppressive therapies and proven in vivo effects. Therefore, our strategy 
may be effective and useful in type 1 diabetes patients in the near future.
Materials and Methods
IPC generation protocol. IPCs were generated by 3D culture with our two-step protocol17. Briefly, this pro-
tocol is based on DeAmour et al.12 and we modified the previous protocol into a two-step differentiation protocol.
ADSC preparation (Step 1). ADSCs (StemPro® Human Adipose-Derived Stem Cells, R7788-115) from 
Invitrogen (Waltham, MA, USA) were cultured in accordance with the manufacturer’s guidelines. After thaw-
ing using established procedures, cells were cultured until passage 5–6, and then 5 × 105 cells were seeded into 
96-well ultra-low attachment plates as 3D culture or 12-well ultra-low attachment plates as conventional culture 
(Sigma-Aldrich Japan Co., LLC., Tokyo, Japan). For Step 1 (Fig. 1A), cells were cultured for 7 days in a differen-
tiation cocktail of DMEM/F12 (Thermo Fisher Scientific Inc., Waltham, MA, USA), 1% human albumin (Wako, 
Osaka, Japan), 1% B27 supplement (Thermo Fisher Scientific), 1% N2 supplement (Thermo Fisher Scientific), 
50 ng/ml activin A (Sigma-Aldrich), 10 nM exendin-4 (Sigma-Aldrich) and with (as 3D culture) or without (as 
conventional 2D culture) 0.1 mg/mL RCP μ-piece (FUJI FILM, Tokyo, Japan).
Differentiation to IPCs (Step 2). For differentiation of ADSCs in 3D or 2D culture, cells were cul-
tured (Fig. 1A) with 50 ng/ml human hepatocyte growth factor (Funakoshi Co., Ltd, Tokyo, Japan), 10 mM 
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nicotinamide (Sigma-Aldrich), and HDACi (valproic acid, Sigma-Aldrich) with (as 3D culture) or without (as 
conventional 2D culture) 0.1 mg/mL RCP μ-piece (FUJI FILM).
Cell counts and purity. Cell number and purity were determined as described previously4,17. Briefly, at 
least three samples of the generated cells were assessed for cell number and purity by staining with dithizone 
dye (Sigma-Aldrich) dissolved in dimethyl sulfoxide (Burdick and Jackson, Morristown, NJ, USA) by light 
microscopy.
Cell viability. Cell viability was assessed as described previously4,17. At least three samples of generated cells 
were stained using the fluorescein diacetate/propidium iodide (FDP/PI) staining kit (TAKARA Bio Inc., Tokyo, 
Japan) and assessed by fluorescence microscopy.
Morphological analysis. We assessed morphological changes of IPCs using a cell fixing kit (Funakoshi). 
Briefly, cells were put in gels and fixed with 10% paraformaldehyde overnight, and 4 μm thick paraffin embedded 
sections were prepared with standard procedure. The sections were stained with haematoxylin-eosin and inves-
tigated with a microscope.
Immunohistochemical staining. Sections were prepared after deparaffinization and antigen retrieval. 
Cells were pelleted by centrifugation, put on a coverslip and incubated with primary antibodies against insu-
lin (aa287-299, LS-B129; LSBio) at a dilution of 1:100 in phosphate-buffered saline (PBS), vascular endothelial 
growth factor (VEGF, bs-0279R, Funakoshi) 1:200 in PBS, C-peptide (bs-0274R, Funakoshi) 1:100 in PBS for 1 h 
at room temperature. Cells were then incubated with biotinylated secondary antibody, followed by treatment with 
a streptavidin-biotin-horseradish peroxidase complex. Positive staining was visualized with diaminobenzidine 
and cell nuclei were counterstained with Mayer’s haematoxylin.
Quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Total RNA was 
extracted from cells using a RNeasy Mini Kit (Qiagen, Hilden, Germany) and cDNA was synthesized from 
2.5 µg of total RNA by reverse transcription using a SuperScript RT kit (Promega, Madison, WI, USA), follow-
ing the manufacturer’s instructions and as previously described41. qRT-PCR was performed using the Applied 
Biosystems 7500 real-time PCR system, TaqMan Gene Expression Assays on demand, and a TaqMan Universal 
Master Mix (gene-specific TaqMan probes on a StepOne Plus; Applied Biosystems, Foster City, CA, USA). MAFA 
(Hs04419852_s1) TaqMan primer was used. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used 
as an internal control for normalization. Expression levels of all genes were calculated as a ratio to GAPDH. 
Amplification data were analysed with an Applied Biosystems Prism 7500 Sequence Detection System version 
1.3.1 (Applied Biosystems).
Cell toxicity assay. Cell toxicity of generated IPCs was investigated using the Cell Counting kit-8 (Fuji 
film-Wako, Osaka, Japan). Briefly, we incubated human dermal fibroblasts (Promo Cell, Heidelberg, Germany) in 
24-well plates for 24 h at 37 °C after cell count. After 24 h co-culture5 at 37 °C with three IPCs per well (a transwell 
system, 0.4 μm pore size membrane; Corning, Acton, MA), the solution of Cell Counting Kit-8 was added. As 
negative control, we added 100 μM 5-Fluorouracil (5-FU, Wako) to fibroblast. Then, the proliferation of fibro-
blasts was analysed by enzyme-linked immunosorbent assay (AKRIN-011H, Shibayagi, Shibukawa, Japan) with 
a microplate reader at a wavelength of 450 nm.
Glucose-stimulated insulin secretion. The glucose stimulation index (SI) of IPCs was calculated as pre-
viously described17. First, IPCs were cultured in RPMI-1640 medium with 5 mM glucose for 1 h and then in 
medium containing 45 mM glucose for 1 h, before being cultured in medium containing 5 mM glucose for an 
additional 1 h. The insulin concentration of the supernatant was analysed by enzyme-linked immunosorbent 
assay (AKRIN-011H, Shibayagi, Shibukawa, Japan) with a microplate reader at a wavelength of 450 nm. Total 
DNA was extracted to determine the cell count. SI was then calculated by dividing the amount of insulin secretion 
from the high glucose incubation by the insulin secretion from the low glucose incubation. Three independent 
experiments were performed.
Electron microscopic analysis. Samples were prepared as previously reported42. Briefly, samples fixed with 
2% paraformaldehyde and 2% glutaraldehyde in 0.1 M phosphate buffer (PB) pH 7.4 at 4 °C overnight. Samples 
were then washed three times with 0.1 M PB for 30 min each and postfixed with 2% osmium tetroxide in 0.1 M 
PB at 4 °C for 2 h. Samples were dehydrated in graded ethanol solutions as follows: 50% and 70% for 10 min, each 
at 4 °C, 90% for 10 min at room temperature, and three changes of 100% for 10 min each at room temperature. 
Samples were then treated with propylene oxide (PO) two times for 30 min each and then placed into a 70:30 
mixture of PO and resin (Quetol-812; Nisshin EM Co., Tokyo, Japan) for 1 h. The cap of the tube was left open 
and PO was volatilized overnight. The samples were transferred to fresh 100% resin and polymerized at 60 °C for 
48 h. The polymerized resins were sectioned ultra-thin at 70 nm with a diamond knife using an ultramicrotome 
(Ultracut UTC; Leica, Vienna, Austria) and the sections were mounted on copper grids. Sections were stained 
with 2% uranyl acetate at room temperature for 15 min and then washed with distilled water, followed by second-
ary staining with lead stain solution (Sigma-Aldrich Co., Tokyo, Japan) at room temperature for 3 min. The grids 
were observed by a transmission electron microscope (JEM-1400Plus; JEOL Ltd., Tokyo, Japan) at an acceleration 
voltage of 100 kV. Digital images (3,296 × 2,472 pixels) were taken with a CCD camera (EM-14830RUBY2; JEOL 
Ltd., Tokyo, Japan).
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Transplantation (in vivo study). Eight-week-old nu-nu nude mice were purchased from CIEA, JAC Inc. 
(Tokyo, Japan) and bred at the Tokushima University animal facility. Mice were intraperitoneally injected with 
200 mg/kg streptozotocin and diabetes was induced. Blood glucose levels were measured with an Accu-chek 
Aviva (Rossi DC Japan Inc., Tokyo, Japan) from the tail vein. The criteria for diabetes were one reading above 
400 mg/dl of blood glucose or two continuous readings above 350 mg/dl. Ninety-six IPCs were transplanted 
under kidney capsule, intra-mesentery and intra-femoral muscle under anaesthesia with Flosen. Non-fasting 
blood glucose levels were measured every two days after transplantation. Recipient mice were sacrificed at day 7 
and day 120 after transplantation, and extirpated organs (IPC transplanted kidneys and mesenteries) were mor-
phologically analysed. The experiments and procedures were approved by the Animal Care and Use Committee 
of the University of Tokushima and were performed in accordance with the NIH Guide for the Care and Use of 
Laboratory Animals.
Statistical analysis. Descriptive statistics are presented as mean ± S.D., median with range for quantitative 
variables and number (percentages) for qualitative variables. Univariate analysis was performed using one-way 
analysis of variation (ANOVA), paired and unpaired t-tests, Scheffe’s test or the Log-rank test, as appropriate. A 
p-value of < 0.05 was considered statistically significant and all p-values reported were two-sided. All analyses 
were performed with State Mate III for Windows (ATMS Co., Tokyo, Japan).
Data Availability
The datasets used and/or analysed in this study are available from the corresponding author upon reasonable 
request.
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